| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.17 | 0.002 |